Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma

Abstract Acute kidney injury (AKI) is a common complication after allogeneic stem cell transplantation; however, its incidence and outcome in patients transplanted for multiple myeloma (MM) is unknown. We evaluated the incidence, severity, and risk factors for AKI within the first 30 days after auto...

Full description

Bibliographic Details
Main Authors: Andreea G. Andronesi, Alina D. Tanase, Bogdan M. Sorohan, Oana G. Craciun, Laura Stefan, Zsofia Varady, Lavinia Lipan, Bogdan Obrisca, Alexandra Truica, Gener Ismail
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2187
_version_ 1818421078507126784
author Andreea G. Andronesi
Alina D. Tanase
Bogdan M. Sorohan
Oana G. Craciun
Laura Stefan
Zsofia Varady
Lavinia Lipan
Bogdan Obrisca
Alexandra Truica
Gener Ismail
author_facet Andreea G. Andronesi
Alina D. Tanase
Bogdan M. Sorohan
Oana G. Craciun
Laura Stefan
Zsofia Varady
Lavinia Lipan
Bogdan Obrisca
Alexandra Truica
Gener Ismail
author_sort Andreea G. Andronesi
collection DOAJ
description Abstract Acute kidney injury (AKI) is a common complication after allogeneic stem cell transplantation; however, its incidence and outcome in patients transplanted for multiple myeloma (MM) is unknown. We evaluated the incidence, severity, and risk factors for AKI within the first 30 days after autologous stem cell transplantation (ASCT) for MM. We prospectively followed 185 consecutive patients with MM, without chronic renal replacement therapy, who underwent ASCT; 12.5% of patients had MM‐associated amyloidosis. AKI occurred in 19 (10.3%) patients, 8 ± 3 days after ASCT, with 18 patients (9.7%) stage 1 and one patient (0.6%) stage 2 AKI. The development of AKI was not associated with reduced overall survival and recovery of kidney function was evident in 68.4% of patients at 3 months. In Cox regression analysis, preexisting–chronic kidney disease (HR 7.01, CI 95% 2.04‐24.09; P = 0.002), serum beta2 microglobulin (HR 3.05, CI 95% 1.10‐8.44; P = 0.03), and mucositis grade 3/4 (HR 1.29, CI 95% 1.08‐1.53; P = 0.003) were independent risk factors for AKI. Our results suggest that AKI occurs with low incidence and reduced severity after ASCT for MM. Prophylactic measures in patients with preexisting–kidney failure may further reduce this risk.
first_indexed 2024-12-14T13:04:38Z
format Article
id doaj.art-88d9f6e2860c4cc89b61ea76e56969d3
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-12-14T13:04:38Z
publishDate 2019-06-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-88d9f6e2860c4cc89b61ea76e56969d32022-12-21T23:00:20ZengWileyCancer Medicine2045-76342019-06-01863278328510.1002/cam4.2187Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myelomaAndreea G. Andronesi0Alina D. Tanase1Bogdan M. Sorohan2Oana G. Craciun3Laura Stefan4Zsofia Varady5Lavinia Lipan6Bogdan Obrisca7Alexandra Truica8Gener Ismail9Nephrology Department Fundeni Clinical Institute Bucharest RomaniaBone Marrow Transplant Department Fundeni Clinical Institute Bucharest RomaniaNephrology Department Fundeni Clinical Institute Bucharest RomaniaBone Marrow Transplant Department Fundeni Clinical Institute Bucharest RomaniaBone Marrow Transplant Department Fundeni Clinical Institute Bucharest RomaniaBone Marrow Transplant Department Fundeni Clinical Institute Bucharest RomaniaBone Marrow Transplant Department Fundeni Clinical Institute Bucharest RomaniaNephrology Department Fundeni Clinical Institute Bucharest RomaniaCarol Davila University of Medicine and Pharmacy Bucharest RomaniaNephrology Department Fundeni Clinical Institute Bucharest RomaniaAbstract Acute kidney injury (AKI) is a common complication after allogeneic stem cell transplantation; however, its incidence and outcome in patients transplanted for multiple myeloma (MM) is unknown. We evaluated the incidence, severity, and risk factors for AKI within the first 30 days after autologous stem cell transplantation (ASCT) for MM. We prospectively followed 185 consecutive patients with MM, without chronic renal replacement therapy, who underwent ASCT; 12.5% of patients had MM‐associated amyloidosis. AKI occurred in 19 (10.3%) patients, 8 ± 3 days after ASCT, with 18 patients (9.7%) stage 1 and one patient (0.6%) stage 2 AKI. The development of AKI was not associated with reduced overall survival and recovery of kidney function was evident in 68.4% of patients at 3 months. In Cox regression analysis, preexisting–chronic kidney disease (HR 7.01, CI 95% 2.04‐24.09; P = 0.002), serum beta2 microglobulin (HR 3.05, CI 95% 1.10‐8.44; P = 0.03), and mucositis grade 3/4 (HR 1.29, CI 95% 1.08‐1.53; P = 0.003) were independent risk factors for AKI. Our results suggest that AKI occurs with low incidence and reduced severity after ASCT for MM. Prophylactic measures in patients with preexisting–kidney failure may further reduce this risk.https://doi.org/10.1002/cam4.2187acute kidney injurymultiple myelomastem cell transplant
spellingShingle Andreea G. Andronesi
Alina D. Tanase
Bogdan M. Sorohan
Oana G. Craciun
Laura Stefan
Zsofia Varady
Lavinia Lipan
Bogdan Obrisca
Alexandra Truica
Gener Ismail
Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
Cancer Medicine
acute kidney injury
multiple myeloma
stem cell transplant
title Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
title_full Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
title_fullStr Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
title_full_unstemmed Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
title_short Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
title_sort incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
topic acute kidney injury
multiple myeloma
stem cell transplant
url https://doi.org/10.1002/cam4.2187
work_keys_str_mv AT andreeagandronesi incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT alinadtanase incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT bogdanmsorohan incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT oanagcraciun incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT laurastefan incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT zsofiavarady incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT lavinialipan incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT bogdanobrisca incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT alexandratruica incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma
AT generismail incidenceandriskfactorsforacutekidneyinjuryfollowingautologousstemcelltransplantationformultiplemyeloma